Mark J. Bradley’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$5.61M Sell
11,965
-7,075
-37% -$2.97M 5.57% 1
2023
Q1
$6.54M Buy
19,040
+1,435
+8% +$484K 4.74% 2
2022
Q4
$6.44M Sell
17,605
-200
-1% -$70.9K 5.73% 1
2022
Q3
$5.76M Sell
17,805
-10
-0.1% -$3.17K 5.33% 1
2022
Q2
$5.78M Sell
17,815
-585
-3% -$176K 5.23% 1
2022
Q1
$5.27M Sell
18,400
-370
-2% -$95.2K 3.76% 5
2021
Q4
$5.18M Sell
18,770
-670
-3% -$170K 3.39% 7
2021
Q3
$4.49M Sell
19,440
-2,630
-12% -$649K 3.07% 9
2021
Q2
$5.07M Sell
22,070
-3,345
-13% -$672K 3.38% 7
2021
Q1
$4.75M Sell
25,415
-1,245
-5% -$244K 3.22% 8
2020
Q4
$4.5M Buy
+26,660
New +$3.98M 3.1% 8

Other funds holding LLY

Mark J. Bradley's LLY Position: Q2 2023 in Review

Mark J. Bradley reduced its Eli Lilly (LLY) stake by 37% in Q2 2023, selling an estimated $2.97M and leaving 11,965 shares worth $5.61M. The position accounts for 5.57% of the portfolio, ranked #1.

Mark J. Bradley first reported a position in LLY in Q4 2020 and has held it in 11 quarters since. The position peaked at $6.54M in Q1 2023. 2,814 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • Mark J. Bradley held 11,965 shares of Eli Lilly worth $5.61M as of Q2 2023.
  • Mark J. Bradley sold 7,075 Eli Lilly shares in Q2 2023, an estimated $2.97M.
  • Eli Lilly made up 5.57% of Mark J. Bradley's portfolio in Q2 2023, its #1 holding.
  • Mark J. Bradley first reported a position in Eli Lilly in Q4 2020 and has held it in 11 quarters since.
  • Mark J. Bradley's Eli Lilly position peaked at $6.54M in Q1 2023.
  • 2,814 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on Mark J. Bradley's 13F filing for Q2 2023, filed 7 Aug 2023.